Wavelength dependency for UVA-induced suppression of recall immunity in humans

Journal of Dermatological Science

Volumn 59, Issue 3, 2010, Pages 192-197

  Matthews, Yasmin J ^a   Halliday, Gary M ^a   Phan, Tai A ^a   Damian, Diona L ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Immunosuppression; Skin carcinogenesis; Ultraviolet; UVA1

Indexed keywords

NICKEL;

ADULT; ARTICLE; CHROMATOPHORE; CONTACT ALLERGY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE DEFICIENCY; IMMUNITY; LIGHT; NICKEL HYPERSENSITIVITY; PRIORITY JOURNAL; RADIATION DOSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ADULT; DERMATITIS, ALLERGIC CONTACT; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; MIDDLE AGED; NICKEL; SKIN; ULTRAVIOLET RAYS;

EID: 77956180291     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.07.005     Document Type: Article

References (37)

1. Diffey B.L. What is light?. Photodermatol Photoimmunol Photomed 2002, 18:68-74.
2. Leiter U., Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv Exp Med Biol 2008, 624:89-103.
3. Halliday G.M. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat Res 2005, 571:107-120.
4. Ullrich S.E. Mechanisms underlying UV-induced immunosuppression. Mutat Res 2005, 571:185-205.
5. Phan T.A., Halliday G.M., Barnetson R.S., Damian D.L. Spectral and dose dependence of ultraviolet radiation-induced immunosuppression. Front Biosci 2006, 11:394-411.
6. Matthews Y.J., Halliday G.M., Phan T.A., Damian D.L. A UVB wavelength dependency for local suppression of recall immunity in humans demonstrates a peak at 300nm. J Invest Dermatol 2010, 130:1680-1684.
7. Byrne S.N., Spinks N., Halliday G.M. Ultraviolet A irradiation of C57BL/6 mice suppresses systemic contact hypersensitivity or enhances secondary immunity depending on dose. J Invest Dermatol 2002, 119:858-864.
8. Damian D.L., Barnetson R.S., Halliday G.M. Low-dose UVA and UVB have different time courses for suppression of contact hypersensitivity to a recall antigen in humans. J Invest Dermatol 1999, 112:939-944.
9. Reeve V.E., Bosnic M., Boehm-Wilcox C., Nishimura N., Ley R.D. Ultraviolet A radiation (320-400nm) protects hairless mice from immunosuppression induced by ultraviolet B radiation (280-320nm) or cis-urocanic acid. Int Arch Allergy Immunol 1998, 115:316-322.
10. Sivapirabu G., Yiasemides E., Halliday G.M., Park J., Damian D.L. Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans. Br J Dermatol 2009, 161:1357-1364.
11. Stapelberg M.P.F., Williams R.B.H., Byrne S.N., Halliday G.M. The alternative complement pathway appears to be a UVA sensor that leads to systemic immunosuppression. J Invest Dermatol 2009, 129:2694-2701.
12. Damian D.L., Halliday G.M. Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans. Methods 2002, 28:34-45.
13. Meding B. Epidemiology of nickel allergy. J Environ Monit 2003, 5:188-189.
14. Stege H., Roza L., Vink A.A., Grewe M., Ruzicka T., Grether-Beck S., et al. Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. PNAS USA 2000, 97:1790-1795.
15. Poon T.S., Barnetson R.S., Halliday G.M. Prevention of immunosuppression by sunscreens in humans is unrelated to protection from erythema and dependent on protection from ultraviolet A in the face of constant ultraviolet B protection. J Invest Dermatol 2003, 121:184-190.
16. Sayre R.M., Kaidbey K.H. Reciprocity for solar simulators used in sunscreen testing. Photodermatol Photoimmunol Photomed 1990, 7:198-201.
17. COLIPA COLIPA sun protection factor test method 1994, 21. The European Cosmetic Toiletry and Perfumery Association, Brussells. R. Macmillan (Ed.).
18. Diffey B.L.R.J. A new substrate to measure sun protection factors throughout the ultraviolet spectrum. J Soc Cosmet Chem 1989, 40:127-133.
19. Sayre R.M.C., Billhimer C., Stanfield W., Ley J.R.D. Spectral comparison of solar simulators and sunlight. Photodermatol Photoimmunol Photomed 1990, 7:159-165.
20. Damian D.L., Barnetson R.S., Halliday G.M. Measurement of in vivo sunscreen immune protection factors in humans. Photochem Photobiol 1999, 70:910-915.
21. Bestak R., Halliday G.M. Chronic low-dose UVA irradiation induces local suppression of contact hypersensitivity, Langerhans cell depletion and suppressor cell activation in C3H/HeJ mice. Photochem Photobiol 1996, 64:969-974.
22. LeVee G.J., Oberhelman L., Anderson T., Koren H., Cooper K.D. UVA II exposure of human skin results in decreased immunization capacity, increased induction of tolerance and a unique pattern of epidermal antigen-presenting cell alteration. Photochem Photobiol 1997, 65:622-629.
23. Ullrich S.E., Nghiem D.X., Khaskina P. Suppression of an established immune response by UVA-a critical role for mast cells. Photochem Photobiol 2007, 83:1000-1095.
24. Bruls W.A., Slaper H., van der Leun J.C., Berrens L. Transmission of human epidermis and stratum corneum as a function of thickness in the ultraviolet and visible wavelengths. Photochem Photobiol 1984, 40:485-494.
25. Poon T.S.C., Barnetson R.S., Halliday G.M. Sunlight-induced immunosuppression in humans is initially because of UVB, then UVA, followed by interactive effects. J Invest Dermatol 2005, 125:840-846.
26. Skov L., Hansen H., Allen M., Villadsen L., Norval M., Barker J.N., et al. Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin. Br J Dermatol 1998, 138:216-220.
27. Persson A.E., Edström D.W., Bäckvall H., Lundeberg J., Pontén F., Ros A.M., et al. The mutagenic effect of ultraviolet-A1 on human skin demonstrated by sequencing the p53 gene in single keratinocytes. Photochem Photobiol 2002, 18:287-293.
28. Iwai I., Hatao M., Kumano Y., Ichihashi M. UVA-induced immune suppression through an oxidative pathway. J Invest Dermatol 1999, 112:19-24.
29. Allanson M., Reeve V.E. Immunoprotective UVA (320-400nm) irradiation upregulates heme oxygenase-1 in the dermis and epidermis of hairless mouse skin. J Invest Dermatol 2004, 122:130-136.
30. Skov L., Villadsen L., Ersboll B.K., Simon J.C., Barker J.N., Baadsgaard O. Long-wave UVA offers partial protection against UVB-induced immune suppression in human skin. APMIS 2000, 108:825-830.
31. Skov L., Hansen H., Barker J.N., Simon J.C., Baadsgaard O. Contrasting effects of ultraviolet-A and ultraviolet-B exposure on induction of contact sensitivity in human skin. Clin Exp Immunol 1997, 107:585-588.
32. Damian D.L., Patterson C.R.S., Stapelberg M., Park J., Barnetson R.S., Halliday G.M. Ultraviolet radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J Invest Dermatol 2008, 128:447-454.
33. Anders A., Altheide H.J., Knalmann M., Tronnier H. Action spectrum for erythema in humans investigated with dye lasers. Photochem Photobiol 1995, 61:200-205.
34. de Gruijl F.R., Sterenborg H.J., Forbes P.D., Davies R.E., Cole C., Kelfkens G., et al. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res 1993, 53:53-60.
35. Setlow R.B., Grist E., Thompson K., Woodhead A.D. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci USA 1993, 90:6666-6670.
36. Agar N.S., Halliday G.M., Barnetson R.S., Ananthaswamy H.N., Wheeler M., Jones A.M. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci USA 2004, 101:4954-4959.
37. Kappes U.P., Luo D., Potter M., Schulmeister K., Runger T.M. Short- and long-wave UV light (UVB and UVA) induce similar mutations in human skin cells. J Invest Dermatol 2006, 126:667-675.